018729314

SequenceFour

---

July 4, 2022

Trademark Summary

The trademark application SequenceFour was filed by CureVac RNA Printer GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). Application under examination.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 1 with Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes and Reagents for research purposes..
• The mark was filed in class 5 with following description of goods:
  
  1. Chemical preparations for medical use, in particular biological macromolecules
  2. Pharmaceutical and veterinary preparations
  3. Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumour diseases, for treatment of metabolic disorders and for treatment of inherited genetic diseases or for protein or enzyme replacement therapy
  4. Gene therapeutic preparations
  5. Health care preparations for medical use
  6. Dietetic substances adapted for medical use, in particular substances for food supplements
  7. Vaccines.
• The mark was filed in class 7 with following description of goods:
  
  1. Machines
  2. Machines for use in chemical or biopharmaceutical industry
  3. Bioreactors
  4. Apparatus for chemical or biological analysis and/or synthesis
  5. Filling machines, in particular for use for filling biopharmaceutical compositions into containers
  6. Industry roboters.
• The mark was filed in class 9 with following description of goods:
  
  1. Apparatus for chemical synthesis
  2. Mobile laboratory
  3. Mobile device for the synthesis of macromolecules
  4. Mobile production station of biological macromolecules.
• The mark was filed in class 42 with following description of goods:
  
  1. Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules
  2. Pre-clinical and clinical testing of macromolecules
  3. Custom synthesis of chemical compounds, in particular biological macromolecules.
• The mark was filed in class 44 with Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders and Vaccination..